06:00 PM EDT, 10/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

HOLX announced an agreement to be acquired by Blackstone and TPG Inc. for $76/share in cash plus a contingent value right (CVR) of up to $3/share, totaling up to $79/share ($18.3B enterprise value). The non-tradable CVR would pay up to $1.50 each in 2026 and 2027 based on achieving certain global revenue goals for HOLX's Breast Health business. The transaction includes minority investments from ADIA and GIC, with committed financing secured. Expected to close in 1H 2026, the deal will help HOLX strengthen its leadership in women's health and accelerate growth while maintaining its headquarters in Massachusetts. The merger agreement includes a 45-day go-shop period allowing Hologic ( HOLX ) to solicit alternative proposals. We believe that HOLX is a strong fit for private equity, given it's a market leader with predictable cash flows, defensive health care exposure, and growth opportunities that can benefit from operational improvements. We up our 12-month target to $79 from $58 to better reflect terms of the deal.